These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 17721197)
1. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis. Torbenson M; Yeh MM; Abraham SC Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197 [TBL] [Abstract][Full Text] [Related]
2. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Wu TT; Levy M; Correa AM; Rosen CB; Abraham SC Cancer; 2009 Oct; 115(19):4564-75. PubMed ID: 19670455 [TBL] [Abstract][Full Text] [Related]
3. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228 [TBL] [Abstract][Full Text] [Related]
4. Bile duct changes in different etiologic types of end-stage chronic liver disease: a study on native explant livers. Jain D; Nayak NC J Clin Pathol; 2012 Apr; 65(4):348-51. PubMed ID: 22135029 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716 [TBL] [Abstract][Full Text] [Related]
7. Intrahepatic cholangiocarcinoma arising in chronic viral hepatitis-associated cirrhosis: two transplant cases. Nart D; Ertan Y; Pala EE; Zeytunlu M; Kilic M; Yilmaz F Transplant Proc; 2008 Dec; 40(10):3813-5. PubMed ID: 19100500 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079 [TBL] [Abstract][Full Text] [Related]
9. Intrahepatic cholangiocarcinoma: new insights in pathology. Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350 [TBL] [Abstract][Full Text] [Related]
10. Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature. Xu AM; Xian ZH; Zhang SH; Chen XF Eur J Gastroenterol Hepatol; 2009 May; 21(5):580-4. PubMed ID: 19282767 [TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma and hepatitis: case study and literature review. Luh F; Kuei A; Fann P; Chu P; Yen Y Anticancer Res; 2009 Aug; 29(8):3239-43. PubMed ID: 19661341 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890 [TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma. Watanabe M; Akagi S; Hamamoto S Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582 [No Abstract] [Full Text] [Related]
14. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244 [TBL] [Abstract][Full Text] [Related]
15. Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases. Nakanuma Y; Xu J; Harada K; Sato Y; Sasaki M; Ikeda H; Kim J; Yu E Pathol Int; 2011 May; 61(5):298-305. PubMed ID: 21501296 [TBL] [Abstract][Full Text] [Related]
16. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273 [TBL] [Abstract][Full Text] [Related]
17. [Cholangiocarcinoma developing in von Meyenburg complexes in haemochromatosis]. Wisniewski B; Tordjman G; Tran Van Nhieu J; Bettan L; Courillon-Mallet A Gastroenterol Clin Biol; 2002 Oct; 26(10):922-4. PubMed ID: 12434102 [TBL] [Abstract][Full Text] [Related]
18. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Hai S; Kubo S; Yamamoto S; Uenishi T; Tanaka H; Shuto T; Takemura S; Yamazaki O; Hirohashi K Dig Surg; 2005; 22(6):432-9. PubMed ID: 16479112 [TBL] [Abstract][Full Text] [Related]
20. [Case-control study of risk factors in cholangiocarcinoma]. Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]